Human Immunodeficiency Virus Mutagenesis during Antiviral Therapy: Impact of Drug-Resistant Reverse Transcriptase and Nucleoside and Nonnucleoside Reverse Transcriptase Inhibitors on Human Immunodeficiency Virus Type 1 Mutation Frequencies

The development of antiviral drug resistance is an important problem in the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Potent antiretroviral therapy is currently used for treatment, and typically consists of at least two reverse transcriptase (RT) inhibitors. We have previou...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Chen, Renxiang, Yokoyama, Masaru, Sato, Hironori, Reilly, Cavan, Mansky, Louis M.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Society for Microbiology 2005
Materias:
Vaccines and Antiviral Agents
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1212631/
https://ncbi.nlm.nih.gov/pubmed/16140780
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/JVI.79.18.12045-12057.2005
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares